How Pharmacy Benefit Managers Are Harming Patients—and What Policymakers Can Do About It
Independent Pharmacies of Maryland
The Costly Failures Of Medicine’s Middlemen
PBM Math: Big Chains Are Paid $23.55 To Fill a Blood Pressure Rx. Small Drugstores? $1.51
Employers Haven’t a Clue How Their Drug Benefits Are Managed
Senators Call on FTC to Investigate PBM Co-Manufacturing Tactic
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
It’s Not Just Big Pharma: Meet the Middlemen Blocking Access to Medication
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
Feds poised to sue pharmacy gatekeepers over high drug costs
Pharmacy benefit managers profit at expense of patients and small pharmacies, FTC says
Maryland could cap prices for Ozempic and other diabetes drugs
Pa. legislators passed a law to regulate pharmacy middlemen. But the state doesn’t enforce it.
3Axis Report Scrutinizes PBM Spread Pricing Practice
Op-Ed: Health care middlemen don’t benefit NJ patients or pharmacists
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Navarro Announces Completion of First Pharmacy Benefit Manager Exams
UnitedHealth Group CEO takes bipartisan heat in Senate hearing over cyberattack
Chains Feeling the Squeeze
David Balto: End the link between PBMs and drug prices